Strides Pharma Receives USFDA Approval for Theophylline Extended-Release Tablets
Strides Pharma Receives USFDA Approval for Theophylline Extended-Release Tablets Strides Pharma Science Ltd, a prominent Indian pharmaceutical company, has achieved a significant milestone by securing approval from the United States Food and Drug Administration (USFDA) for its generic version of Theophylline extended-release tablets. This approval marks a crucial step in providing cost-effective treatment options for respiratory conditions such … Read more